You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 44.195.0.0/16 has been blocked (disabled) by ‪Blablubbs‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider or colocation provider. To prevent abuse, web hosts and colocation providers may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host or colocation provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a colocation provider's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a colocation web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host or colocation provider (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host or colocation provider.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and requests should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 09:46, 11 January 2025.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪AntiCompositeNumber‬. The reason given is Open proxy/Webhost: Visit the FAQ if you are affected .
- Start of block: 13:55, 18 August 2022
- Expiry of block: 13:55, 18 January 2025
Your current IP address is 44.195.68.6. The blocked range is 44.195.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

((Multiple issues|
((overly detailed|date=February 2013))
((more citations needed|date=February 2013))
))

((Infobox company
| name = Bracco S.p.A.
| logo = [[Image:Bracco Logo.svg|180px|Bracco]]
| type = [[Privately held company|Private]] (family-owned)
| foundation = 1927
| founder = Elio Bracco
| location_country = [[Milan, Italy]]
| area_served = Worldwide
| key_people = Diana Bracco (President and CEO)
| industry = Chemical, pharmaceutical
| products = contrast agents, injectors, medical devices, pharma
| revenue = ((profit)) ((currency|1.3 billion|eur))<ref name="Dati2015">((Cite web|title=Financial Highlights|url=http://www.bracco.com/index.php?option=com_content&view=article&id=13&Itemid=108&lang=en_GB|editor=Bracco SpA|language=en,it|year=2012|access-date=14 February 2015|archive-url=https://web.archive.org/web/20121119230258/http://www.bracco.com/index.php?option=com_content&view=article&id=13&Itemid=108&lang=en_GB|archive-date=19 November 2012|url-status=dead))</ref>
| num_employees = 3400 (2015)
| website = ((URL|http://www.bracco.com))
))

The '''Bracco Group''' is an Italian multinational active in the healthcare sector with more than 3,300 employees worldwide,<ref name="Dati2012">((Cite web|title=Financial Highlights|url=http://www.bracco.com/index.php?option=com_content&view=article&id=13&Itemid=108&lang=en_GB|editor=Bracco SpA|language=en,it|year=2012|access-date=14 February 2013|archive-url=https://web.archive.org/web/20121119230258/http://www.bracco.com/index.php?option=com_content&view=article&id=13&Itemid=108&lang=en_GB|archive-date=19 November 2012|url-status=dead))</ref> which operates in a variety of business areas.<ref name="Dati2012" />
*[[Diagnostic imaging]], with products for [[X-ray imaging]], including [[computed tomography]] (CT), [[magnetic resonance imaging]] (MRI), [[ultrasound]] and [[nuclear medicine]].
*[[Rubidium-82|Contrast-agent injection systems and advanced medical devices.]]
*Prescription and over-the-counter [[pharmaceuticals]], supplements, medical and [[cosmetics|cosmetic]] devices developed and distributed in Italy.
*Healthcare, [[preventive medicine|prevention]], [[diagnosis]] and [[Physical medicine and rehabilitation|rehabilitation]] services through the CDI - Centro Diagnostico Italiano.
Bracco has consolidated revenues of more than 1.1 billion euro, of which 75% from international sales.<ref>((Cite web|title=Fatturato per Aree geografiche|url=http://www.bracco.com/index.php?option=com_content&view=article&id=15&Itemid=110&lang=it_IT|editor=Bracco SpA|language=en, it|year=2013|access-date=14 February 2013|archive-url=https://web.archive.org/web/20110213091024/http://www.bracco.com/index.php?option=com_content&view=article&id=15&Itemid=110&lang=it_IT|archive-date=13 February 2011|url-status=dead))</ref> The Group is present in 100 countries and invests approximately 10% of its core diagnostic imaging revenues in research and innovation.
In Italy Bracco is also a brand associated with a number of historic pharmaceutical products such as Cebion, Xamamina, Euclorina, the Alfa eye-drops line and the Friliver range of sport supplements.

The Group Chairman and Chief Executive Officer is Diana Bracco. A [[chemistry]] graduate from the [[University of Pavia]], Diana Bracco is also Chairman of [[Expo 2015]] Spa, General Section Commissioner for the Italy Pavilion at Expo and [[Confindustria]] Vice President for Research & Innovation. Decorated as a Cavaliere del Lavoro, she was President of Assolombarda and, before that, Chairman of Federchimica. In February 2001 she received an Honorary Doctor of Pharmacy degree from [[University of Pavia]].
On January 12, 2015, Diana Bracco was "prosecuted on charges of tax evasion and embezzlement, crimes allegedly committed as chairman of the board of the pharmaceutical group Bracco Spa."<ref name="urlEvasione, case e yacht ristrutturati con i soldi della società: Diana Bracco rinviata a giudizio a Milano - Repubblica.it">((cite web | url = http://milano.repubblica.it/cronaca/2016/01/12/news/milano_diana_bracco_rinviata_a_giudizio_e_accusata_di_evasione_fiscale-131108745/ | title = Evasione, "case e yacht ristrutturati con i soldi della società": Diana Bracco rinviata a giudizio a Milano - Repubblica.it | publisher =Repubblica.it| language =it | access-date = 2016-01-12))</ref><ref name="urlDiana Bracco, a processo per evasione fiscale il vicepresidente di Confindustria - Il Fatto Quotidiano">((cite web | url = http://www.ilfattoquotidiano.it/2016/01/12/diana-bracco-a-processo-per-evasione-fiscale-il-vicepresidente-di-confindustria/2368885/ | title = Diana Bracco, a processo per evasione fiscale il vicepresidente di Confindustria - Il Fatto Quotidiano | author = F. Q.  | publisher =  Il Fatto Quotidiano | language =it | access-date = 2016-01-12))</ref><ref name="urlExpo Milano 2015 president Diana Bracco faces embezzlement and tax evasion probe">((cite web | url = http://www.ibtimes.co.uk/expo-milano-2015-president-diana-bracco-faces-embezzlement-tax-evasion-probe-1503534 | title = Expo Milano 2015 president Diana Bracco faces embezzlement and tax evasion probe | author = Umberto Bacchi| date = May 29, 2015|publisher =  IBTimes Co., Ltd.|language = en |access-date = 2015-06-19))</ref><ref>[http://uk.reuters.com/article/uk-italy-expo-probe-idUKKBN0OE2FD20150529 President of Milan Expo investigated for tax evasion, embezzlement May 29, 2015]</ref> In October 2016, she was given a two year suspended sentence for tax fraud and embezzlement.<ref>[http://www.ansa.it/english/news/2016/10/19/ex-confindustria-vp-gets-two-years-for-tax-fraud-2_ab86d09a-0da8-47f7-8c4c-6931ad038d8f.html Ex-Confindustria VP gets two years for tax fraud], 19 October 2010 [[Agenzia Nazionale Stampa Associata]], retrieved 15 April 2018</ref>

As of 2020, the group has a consolidated turnover of approximately 1.4 billion euros, of which 89% on foreign markets. It is present in 100 countries with 3,587 employees.<ref>((cite web |url=http://corporate.bracco.com/it-it/il-gruppo |title=Il Gruppo |website=Bracco Corporate |access-date=25 May 2017 |language=it))</ref> The Bracco group has 1,800 patents, 7 research and development centers and 9 factories worldwide.<ref>((cite news |title=Bracco - Ultime notizie su Bracco - Argomenti del Sole 24 Ore|url=http://argomenti.ilsole24ore.com/bracco.html|magazine=Argomenti Argomenti del Sole 24 Ore|access-date=25 May 2017))</ref>

== History==
The company founded by Elio Bracco was established in 1927 in Milan with the name Società Italiana Prodotti E Merck, to produce, package and sell the chemical products of the German company [[Merck Group#History|E. Merck]]. It had just five employees.
In 1934 Fulvio Bracco, Elio's son, officially joined the company which, the same year, began marketing Cebion, an innovative product based on vitamin C, recently discovered by the Hungarian biochemist [[Albert Szent-Györgyi]]. In 1962 Bracco researchers created the first contrast agent based on their original [[research]]: iodamide, a product with very high tolerability.
On 17 March 1977 Diana Bracco, Fulvio's daughter, was appointed Bracco General Manager.

In 1981 the company launched Iopamidol in Italy and Germany. In the second half of the 1980s, Bracco Spa became the leading international producer of non-ionic contrast agents. It also won a positive response and important results for other formulations, including the anti-tuberculosis drug pyrazinamide, of which Bracco is the leading world producer, which is included in the WHO list of essential [[pharmaceuticals]].((citation needed|date=June 2021))

In 1990, Bracco began a ten-year period of important growth. At international level, acquisitions and [[joint ventures]] enhanced the Group structure. In 1990 the Bracco Eisai [[joint venture]] was set up in Japan. In 1994 Bracco acquired Squibb Diagnostic, a company in the Bristol Myers Squibb group in the United States, which is still Bracco Imaging's largest market today.
1995 saw the integration of the three research centres in [[Milan]], [[Geneva]] and [[Princeton University|Princeton]]: [[Milan]] focuses on the [[research]] and development of contrast agents for [[radiology]] and [[magnetic resonance imaging|magnetic resonance]], Bracco Research Geneva on ultrasound and Bracco Research USA Princeton on magnetic resonance and [[nuclear medicine]].

1999 was a milestone year for the company: the Bracco family and the [[Merck Group]] reached an agreement under which Bracco bought Merck's 50% stake in the Group's diagnostic and pharmaceuticals operations.
In 2001, the Bracco Group acquired ACIST Medical Systems, a US company based in [[Eden Prairie, MN|Eden Prairie, Minnesota]], a suburb of [[Minneapolis]], active in advanced contrast-agent management and injection systems.
Meanwhile, the Group's international growth continued, with more offices opening around the world. Since 2002 Bracco has had a direct presence in China with Bracco Sine Pharmaceutical Corp. Ltd. in Shanghai. In 2008 it acquired E-Z-EM, a leading company in the [[radiology]] sector. In 2010 Bracco entered [[Estonia]], [[Scandinavia]] and [[South Korea]]. In 2011 Bracco Imaging acquired Swiss Medical Care (now Bracco Injeneering) and the Nycomed production plants in Singen (Germany). In 2012 it completed the acquisitions of Justesa in [[Argentina]], Mexico and [[Brazil]].

<ref>"From Neresine to Milan. Memories of the Italian Entrepreneur Fulvio Bracco" edited by Bracco Foundation, year 2012</ref>

== Gruppo Companies==
((Div col|small=yes))
*Bracco S.p.A. - [[Milan]] (Italy)
*Bracco Imaging S.p.A. - [[Milan]] (Italy)
*Bracco Imaging Italia S.p.A.- Italia- [[Milan]] (Italy)
*SPIN  S.p.A. - [[Torviscosa]] (Italy)
*Centro Diagnostico Italiano S.p.A. - [[Milan]] (Italy)
*Bracco Imaging Europe BV - ([[Netherlands]])
*Bracco Imaging Europe BV - (Belgium)
*Bracco Suisse S.A. (Switzerland)
*Bracco International BV ([[Netherlands]])
*Bracco Imaging Polska- ([[Poland]])
*Bracco Imaging Czech- ([[Czech Republic]])
*Bracco Imaging Deutschland GmbH- (Germany)
*Bracco Imaging BV- (France)
*Bracco UK  Ltd.  (United Kingdom)
*Bracco Oesterreich GmbH (Austria)
*Bracco Imaging France SAS (France)
*Bracco Imaging Scandinavia AB (Sweden)
*Bracco Imaging Baltics ([[Estonia]])
*ACIST Europe B.V ([[Netherlands]])
*BIPSO - (Germany)
*Bracco Imaging Slovakia- ([[Slovakia]])
*Bracco Injeneering - ([[Switzerland]])
*Bracco Research U.S.A. Inc.-  (United States)
*Bracco  Diagnostics Inc. - (United States)
*ACIST Medical Systems, Inc - (United States)
*E-Z-EM Canada (Bracco Imaging Canada) - (Canada)
*Bracco Imaging do Brasil importaçao e distribuçao de medicamentos L.tda - ([[Brasil]])
*Justesa Imagen Mexicana S.A. de C.V- (Mexico)
*Bracco  Diagnostics Asia, Pty- ([[Singapore]])
*Bracco International BV-  - (China)
*Bracco Eisai  Co. Ltd.-  (Japan)
*Shanghai Bracco Sine Pharmaceutical Corp. Ltd. (China)
*Bracco Far East Ltd.- (China)
*Bracco Far East Ltd. – ([[Hong Kong]])
*Bracco Imaging Korea Ltd. – ([[South Korea]])
*ACIST Asia Pte Ltd – ([[Singapore]])
((Div col end))

== References ==
((Reflist))

((Authority control))

[[Category:Multinational companies headquartered in Italy]]
[[Category:Chemical companies of Italy]]
[[Category:Pharmaceutical companies of Italy]]
[[Category:Pharmaceutical companies established in 1927]]
[[Category:Manufacturing companies based in Milan]]
[[Category:Italian companies established in 1927]]
[[Category:Italian brands]]

Pages transcluded onto the current version of this page (help):

Bracco (company) (edit)
Template:Ambox (view source) (template editor protected)
Template:Authority control (view source) (template editor protected)
Template:Category handler (view source) (protected)
Template:Citation needed (view source) (protected)
Template:Cite news (view source) (protected)
Template:Cite web (view source) (protected)
Template:Comma separated entries (view source) (template editor protected)
Template:Currency (view source) (extended confirmed protected)
Template:DMCA (view source) (template editor protected)
Template:Dated maintenance category (view source) (template editor protected)
Template:Dated maintenance category (articles) (view source) (template editor protected)
Template:Delink (view source) (protected)
Template:Div col (view source) (template editor protected)
Template:Div col/styles.css (view source) (template editor protected)
Template:Div col end (view source) (template editor protected)
Template:FULLROOTPAGENAME (view source) (template editor protected)
Template:Find sources mainspace (view source) (template editor protected)
Template:Fix (view source) (protected)
Template:Fix/category (view source) (protected)
Template:Hlist/styles.css (view source) (protected)
Template:Increase (view source) (template editor protected)
Template:Infobox (view source) (template editor protected)
Template:Infobox company (view source) (template editor protected)
Template:Longitem (view source) (template editor protected)
Template:Main other (view source) (protected)
Template:More citations needed (view source) (template editor protected)
Template:Multiple issues (view source) (template editor protected)
Template:Multiple issues/styles.css (view source) (template editor protected)
Template:Ns has subpages (view source) (protected)
Template:Overly detailed (view source) (extended confirmed protected)
Template:Profit (view source) (template editor protected)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:Template other (view source) (protected)
Template:URL (view source) (template editor protected)
Module:Arguments (view source) (protected)
Module:Authority control (view source) (template editor protected)
Module:Authority control/auxiliary (view source) (template editor protected)
Module:Authority control/config (view source) (template editor protected)
Module:Category handler (view source) (protected)
Module:Category handler/blacklist (view source) (protected)
Module:Category handler/config (view source) (protected)
Module:Category handler/data (view source) (protected)
Module:Category handler/shared (view source) (protected)
Module:Check for clobbered parameters (view source) (template editor protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Currency (view source) (extended confirmed protected)
Module:Currency/Presentation (view source) (extended confirmed protected)
Module:Delink (view source) (protected)
Module:EditAtWikidata (view source) (protected)
Module:Find sources (view source) (template editor protected)
Module:Find sources/config (view source) (template editor protected)
Module:Find sources/links (view source) (template editor protected)
Module:Find sources/templates/Find sources mainspace (view source) (template editor protected)
Module:Infobox (view source) (template editor protected)
Module:Infobox/styles.css (view source) (template editor protected)
Module:InfoboxImage (view source) (template editor protected)
Module:Message box (view source) (protected)
Module:Message box/ambox.css (view source) (protected)
Module:Message box/configuration (view source) (protected)
Module:Namespace detect/config (view source) (protected)
Module:Namespace detect/data (view source) (protected)
Module:Navbar (view source) (protected)
Module:Navbar/configuration (view source) (protected)
Module:Navbox (view source) (template editor protected)
Module:Navbox/configuration (view source) (template editor protected)
Module:Navbox/styles.css (view source) (template editor protected)
Module:Ns has subpages (view source) (protected)
Module:Separated entries (view source) (protected)
Module:String (view source) (protected)
Module:TableTools (view source) (protected)
Module:URL (view source) (template editor protected)
Module:Unsubst (view source) (protected)
Module:WikidataIB (view source) (template editor protected)
Module:WikidataIB/nolinks (view source) (template editor protected)
Module:WikidataIB/titleformats (view source) (template editor protected)
Module:Yesno (view source) (protected)

Return to Bracco (company).

Retrieved from "https://en.wikipedia.org/wiki/Bracco_(company)"